Sarepta Therapeutics says it will file a supplemental BLA for Elevidys (delandistrogene moxeparvovec-rokl) to expand the therapys use in all patients ...
GSK says a Phase 3 trial evaluating its Jemperli (dostarlimab) in adult patients with primary advanced or recurrent endometrial cancer met its primary...
Novartis says it will seek FDA accelerated approval for atrasentan and its use in treating patients with IgA nephropathy.
FDA approves Impulse Dynamics Optimizer Smart Mini system for whole-body MRI-conditional use.
Deciphera Pharmaceuticals says it will file an NDA in the second quarter of 2024 for vimseltinib for treating patients with tenosynovial giant cell tu...
FDA approves an Eli Lilly BLA for Omvoh (mirikizumab-mrkz) infusion, described as the first interleukin-23p19 (IL-23p19) antagonist for treating moder...
A federal court in Texas sentences Evan Asher Field to five years in prison for selling unapproved drugs through the mail.
FDA approves Genentechs Vabysmo (faricimab-svoa) for treating macular edema following retinal vein occlusion.
